Dr. sc. med. Elena Gross is the founder and CEO of KetoSwiss, a Swiss biotech startup, winner of this year's Top 100 Swiss startup public award. KetoSwiss develops highly potent therapeutic ketones for neurological disease prevention.
Elena started her career in academia. She used to be a chronic migraine patient and due to the lack of tolerable and efficacious treatment options, she pursued an MSc in Neuroscience at theUniversity of Oxford. There, she discovered ketone bodies & their potential therapeutic use in neurological disease, which changed her life.
Entrepreneurial in spirit, she is the inventor of two patents. She also initiated & funded the first ever clinical trial using exogenous ketone body salts in the world in her PhD at the University of Basel and University of Harvard Medical School.
Studying further with an entrepreneurship at the University of Cambridge, Elena continues to blend the best of the research and startup ecosystems.